Neurointervention.  2022 Mar;17(1):2-17. 10.5469/neuroint.2021.00465.

Imaging in Acute Anterior Circulation Ischemic Stroke: Current and Future

Affiliations
  • 1Department of Radiology, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
  • 2Department of Radiology, Konkuk University Medical Center, Seoul, Korea

Abstract

Clinical trials on acute ischemic stroke have demonstrated the clinical effectiveness of revascularization treatments within an appropriate time window after stroke onset: intravenous thrombolysis (NINDS and ECASS-III) through the administration of tissue plasminogen activator within a 4.5-hour time window, endovascular thrombectomy (ESCAPE, REVASCAT, SWIFT-PRIME, MR CLEAN, EXTEND-IA) within a 6-hour time window, and extending the treatment time window up to 24 hours for endovascular thrombectomy (DAWN and DEFUSE 3). However, a substantial number of patients in these trials were ineligible for revascularization treatment, and treatments of some patients were considerably futile or sometimes dangerous in the clinical trials. Guidelines for the early management of patients with acute ischemic stroke have evolved to accept revascularization treatment as standard and include eligibility criteria for the treatment. Imaging has been crucial in selecting eligible patients for revascularization treatment in guidelines and clinical trials. Stroke specialists should know imaging criteria for revascularization treatment. Stroke imaging studies have demonstrated imaging roles in acute ischemic stroke management as follows: 1) exclusion of hemorrhage and stroke mimic disease, 2) assessment of salvageable brain, 3) localization of the site of vascular occlusion and thrombus, 4) estimation of collateral circulation, and 5) prediction of acute ischemic stroke expecting hemorrhagic transformation. Here, we review imaging methods and criteria to select eligible patients for revascularization treatment in acute anterior circulation stroke, focus on 2019 guidelines from the American Heart Association/American Stroke Association, and discuss the future direction of imaging-based patient selection to improve treatment effects.

Keyword

Acute ischemic stroke; Computed tomography, X-ray; Magnetic resonance imaging; Angiography; Perfusion; Collateral circulation

Figure

  • Fig. 1. Images at admission of an elderly patient who presented with dysarthria and right-sided weakness at 2 and half hours after last known normal state. The premorbid modified Rankin scale score of this patient was 0, and the National Institutes of Health Stroke Scale score at admission was 23. (A) Ganglionic level and (B) supraganglionic level, noncontrast computer tomography (NCCT) images show loss of gray-white matter differentiation at insula, M2, M3, M4, and M5 of the left middle cerebral artery territory, and the Alberta Stroke Program Early CT Score (ASPECTS) is 5 visually. (C) Computer-aid automated ASPECTS is 7 (RAPID, RapidAI®, Menlo Park, CA, USA). (D) Computed tomography angiography (CTA) shows occlusion of the left internal carotid and middle cerebral arteries. (E–G) The first (E), second (F), and third phase (G) collateral images derived from multiphase CTA show a filling delay of 2 phases in the affected hemisphere with a significantly reduced number of vessels in the ischemic territory (multiphase CTA collateral score 2). (H) CT perfusion (CTP) Tmax threshold >6 seconds (Tmax >6 s) map indicates near whole left middle cerebral artery territory as penumbra (red zone). (I) Automated software (RAPID, RapidAI®) demonstrates the volume data of core and penumbra and mismatch ratio between the penumbra and core, which are 93 mL with a threshold of CTP cerebral blood flow <30% and 132 mL with threshold of a Tmax > 6 s and 1.4, respectively. (J) Ganglionic level and (K) supraganglionic level, diffusion-weighted magnetic resonance images (DWI) obtained 10 minutes after CT scan show a large core involving the entire left middle cerebral artery territory. (L–O) Images of arterial (L), capillary (M), early venous (N), and late venous (O) phases of the collateral map derived from dynamic contrast-enhanced magnetic resonance angiography show very poor collateral perfusion status (MAC score of 0) [38] defined as collateral perfusion delay/defect more than one-half of affected middle cerebral artery territory remained until the late venous phase. DWI (J, K) and the collateral map (L–O) indicate that the core rapidly progresses to infarction. According to current guidelines, she should receive intravenous thrombolysis (IVT) after scanning NCCT (A, B). Even though the visually estimated NCCT ASPECTS is 5, it is not easy to exclude her from endovascular thrombectomy (EVT) because it is difficult to accept the NCCT ASPECTS. In addition, the automated ASPECTS is 7 (C), which is an eligible score for EVT. The result of automated software is dependent on the quality of the learning material, which is used as ground truth in deep learning. Automated ASPECTS is limited in accuracy due to the inconspicuousness of NCCT. We can see another result of the automated core size estimated with a threshold of CTP cerebral blood flow <30% (I), which is different from the results of visual and automated estimation. It is inevitably limited to measuring cores containing heterogeneous factors regarding occluded duration, collateral status, and cellular composition with different ischemic resistance as a fixed threshold value. This indirect method of core assessment is also due to the inconspicuousness of NCCT, and this is a major limitation of CT workup in acute ischemic stroke despite its availability and rapidity. However, DWI shows a far-progressed large infarction directly and clearly (J, K). We do not need to hesitate excluding her from EVT. At current guidelines, there is no basis for excluding her from IVT or for further imaging work-up except NCCT. We have no choice but to inject recombinant tissue plasminogen activator (rt-PA). However, through this case, we can understand the significant ratio of futile or dangerous treatments in current guidelines.

  • Fig. 2. Images of an elderly patient who developed left-sided weakness 2 hours prior. (A) Diffusion-weighted magnetic resonance imaging at admission shows a core involving the whole right middle cerebral artery territory. (B) Time-of-flight magnetic resonance angiography (TOF-MRA) and (C) computed tomography angiography (CTA) show occlusion from the right proximal internal carotid artery (ICA) to the ipsilateral middle cerebral artery. (D) Early phase image of dynamic contrast-enhanced magnetic resonance angiography (DCE-MRA) shows the same finding as that of TOF-MRA and CTA. (E) More delayed phase image than (D) of DCE-MRA reveals delayed flow of the ICA reaching the cavernous segment (white arrows). (F) Catheter digital subtraction angiography reveals the patent right proximal ICA (black arrows) and occlusion of the C1 segment of the right ICA (*).

  • Fig. 3. Images of a middle aged patient who developed left-sided weakness 30 minutes prior. Her premorbid modified Rankin scale score was 0, and the National Institutes of Health Stroke Scale score at admission was 11. She underwent intravenous thrombolysis followed by intraarterial thrombectomy, but recanalization of the occluded arteries was not achieved, as shown by a modified Thrombolysis in Cerebral Infarction scale score of 2a. (A) Noncontrast computed tomography image at admission shows less distinction of the right basal ganglia than the left basal ganglia. (B) Diffusion-weighted magnetic resonance imaging (DWI) at admission shows a core involving the insula, caudate nucleus, basal ganglia, internal capsule, M1, cortical area of M2 and M3, and some periventricular white matter of M3 on the right middle cerebral artery territory. (C) Dynamic contrast-enhanced magnetic resonance angiography (DCE-MRA) at admission shows occlusion of the right internal carotid and middle cerebral arteries. (D) MR perfusion Tmax threshold >6 seconds (Tmax >6 s) map at admission shows penumbra (white zone) matched with the core. (E) DWI on Day 1 shows a significantly increased extent of the core on DWI at admission due to reperfusion failure. (F–J) Images of arterial (F), capillary (G), early venous (H), late venous (I), and delay (J) phases of collateral map derived from DCE-MRA show intermediate to poor collateral perfusion status (MAC score of 2) [38] defined as collateral perfusion delay/defect more than one-half of affected middle cerebral artery territory in the capillary phase and equal to or less than one-half in the early venous phase. Because there was no target mismatch on Tmax >6 s (D), despite no penumbra on Tmax >6 s, the extent of the baseline core increased as much as the hypoperfused area on the capillary phase of the collateral map at admission, and the extent of the baseline core coincided with the hypoperfused area in the early venous phase.

  • Fig. 4. Images of an elderly patient who developed left-sided weakness 4 hours prior. His premorbid modified Rankin scale score was 0, and the National Institutes of Health Stroke Scale score at admission was 10. He was ineligible for IVT because he was taking an oral anticoagulant for arterial fibrillation. (A) Diffusion-weighted magnetic resonance imaging (DWI) at admission shows the core mainly involving more than one-third of the right middle cerebral artery (MCA) territory. (B) Dynamic contrast-enhanced magnetic resonance angiography (DCE-MRA) at admission shows partial occlusion at the first bifurcation of the right MCA. (C) MR perfusion Tmax threshold >6 seconds (Tmax 7>6 s) map at admission shows penumbra (white zone) larger than the core representing target mismatch. Catheter digital subtraction angiography performed prior to endovascular thrombectomy (EVT) revealed distal migration of fragmented thrombi to the M3 and M4 branches of the right MCA, so EVT did not undergo. (D) DWI on Day 1 shows that most of the baseline DWI lesions were reversed except for two tiny infarct signals. (E–I) Images of arterial (E), capillary (F), early venous (G), late venous (H), and delay (I) phases of collateral map derived from DCE-MRA show good collateral perfusion status (MAC score of 4) [38] defined as collateral perfusion delay equal to or less than one-half of affected MCA territory in the capillary phase and no or a small delay in the early venous phase.


Cited by  1 articles

Impact of Collateral Circulation on Futile Endovascular Thrombectomy in Acute Anterior Circulation Ischemic Stroke
Yoo Sung Jeon, Hyun Jeong Kim, Hong Gee Roh, Taek-Jun Lee, Jeong Jin Park, Sang Bong Lee, Hyung Jin Lee, Jin Tae Kwak, Ji Sung Lee, Hee Jong Ki
J Korean Neurosurg Soc. 2024;67(1):31-41.    doi: 10.3340/jkns.2023.0139.


Reference

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–1587.
2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, ECASS Investigators, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359:1317–1329.
Article
3. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372:1019–1030.
Article
4. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, REVASCAT Trial Investigators, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015; 372:2296–2306.
Article
5. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, SWIFT PRIME Investigators, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372:2285–2295.
Article
6. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, MR CLEAN Investigators, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20 Erratum in: N Engl J Med. 2015; 372:394.
Article
7. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372:1009–1018.
Article
8. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, DAWN Trial Investigators, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018; 378:11–21.
9. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, DEFUSE 3 Investigators, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018; 378:708–718.
Article
10. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50:e344-e418 Erratum in: Stroke. 2019; 50:e440–e441.
11. Liebeskind DS. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am. 2005; 15:553–573.
Article
12. Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol. 2011; 10:909–921.
Article
13. Molina CA. Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke. 2010; 41:842–843.
Article
14. Wufuer A, Wubuli A, Mijiti P, Zhou J, Tuerxun S, Cai J, et al. Impact of collateral circulation status on favorable outcomes in thrombolysis treatment: a systematic review and meta-analysis. Exp Ther Med. 2018; 15:707–718.
Article
15. Wintermark M, Rowley HA, Lev MH. Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro CT. Radiology. 2009; 251:619–626.
Article
16. Köhrmann M, Schellinger PD. Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imaging. Radiology. 2009; 251:627–633.
Article
17. Na DG, Sohn CH, Kim EY. Imaging-based management of acute ischemic stroke patients: current neuroradiological perspectives. Korean J Radiol. 2015; 16:372–390.
Article
18. Schlemm L, Endres M, Werring DJ, Nolte CH. Benefit of intravenous thrombolysis in acute ischemic stroke patients with high cerebral microbleed burden. Stroke. 2020; 51:232–239.
Article
19. Charidimou A, Shoamanesh A; International META-MICROBLEEDS Initiative. Clinical relevance of microbleeds in acute stroke thrombolysis: comprehensive meta-analysis. Neurology. 2016; 87:1534–1541.
Article
20. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999; 30:1528–1533.
Article
21. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta stroke programme early CT score. Lancet 2000;355:1670-1674 Erratum in. Lancet. 2000; 355:2170.
22. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, HERMES collaborators, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387:1723–1731.
Article
23. Purushotham A, Campbell BC, Straka M, Mlynash M, Olivot JM, Bammer R, et al. Apparent diffusion coefficient threshold for delineation of ischemic core. Int J Stroke. 2015; 10:348–353.
Article
24. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke. 2010; 41:2817–2821.
Article
25. Cereda CW, Christensen S, Campbell BCV, Mishra NK, Mlynash M, Levi C, et al. A benchmarking tool to evaluate computer tomography perfusion infarct core predictions against a DWI standard. J Cereb Blood Flow Metab. 2016; 36:1780–1789.
Article
26. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, EPITHET investigators, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7:299–309.
Article
27. Thomalla G, Boutitie F, Fiebach JB, Simonsen CZ, Nighoghossian N, Pedraza S, WAKE-UP Investigators, et al. Stroke with unknown time of symptom onset: baseline clinical and magnetic resonance imaging data of the first thousand patients in wake-up (efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomized, doubleblind, placebo-controlled trial). Stroke. 2017; 48:770–773.
28. Odland A, Særvoll P, Advani R, Kurz MW, Kurz KD. Are the current MRI criteria using the DWI-FLAIR mismatch concept for selection of patients with wake-up stroke to thrombolysis excluding too many patients? Scand J Trauma Resusc Emerg Med. 2015; 23:22.
Article
29. Broocks G, Leischner H, Hanning U, Flottmann F, Faizy TD, Schön G, et al. Lesion age imaging in acute stroke: water uptake in CT versus DWI-FLAIR mismatch. Ann Neurol. 2020; 88:1144–1152.
Article
30. Le Bras A, Raoult H, Ferré JC, Ronzière T, Gauvrit JY. Optimal MRI sequence for identifying occlusion location in acute stroke: which value of time-resolved contrast-enhanced MRA? AJNR Am J Neuroradiol. 2015; 36:1081–1088.
Article
31. Ko HC, Ryu CW, Yun SJ, Koh JS, Shin HS, Kim EJ. Characteristic signs on T2*-based imaging and their relationship with results of reperfusion therapy for acute ischemic stroke: a systematic review and evidence to date. Neurointervention. 2018; 13:90–99.
Article
32. Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW, et al. Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol. 2011; 32:1640–1645.
Article
33. Menon BK, d’Esterre CD, Qazi EM, Almekhlafi M, Hahn L, Demchuk AM, et al. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology. 2015; 275:510–520.
Article
34. Berkhemer OA, Jansen IG, Beumer D, Fransen PS, van den Berg LA, Yoo AJ, MR CLEAN Investigators, et al. Collateral status on baseline computed tomographic angiography and intra-arterial treatment effect in patients with proximal anterior circulation stroke. Stroke. 2016; 47:768–776.
Article
35. Jadhav AP, Diener HC, Bonafe A, Pereira VM, Levy EI, Baxter BW, SWIFT PRIME investigators, et al. Correlation between clinical outcomes and baseline CT and CT angiographic findings in the SWIFT PRIME trial. AJNR Am J Neuroradiol. 2017; 38:2270–2276.
Article
36. Faizy TD, Kabiri R, Christensen S, Mlynash M, Kuraitis GM, Broocks G, et al. Favorable venous outflow profiles correlate with favorable tissue-level collaterals and clinical outcome. Stroke. 2021; 52:1761–1767.
Article
37. Roh HG, Kim EY, Kim IS, Lee HJ, Park JJ, Lee SB, et al. A novel collateral imaging method derived from time-resolved dynamic contrast-enhanced MR angiography in acute ischemic stroke: a pilot study. AJNR Am J Neuroradiol. 2019; 40:946–953.
Article
38. Kim HJ, Lee SB, Choi JW, Jeon YS, Lee HJ, Park JJ, et al. Multiphase MR angiography collateral map: functional outcome after acute anterior circulation ischemic stroke. Radiology. 2020; 295:192–201.
Article
39. Lee TJ, Roh HG, Kim JH, Lee SB, Park JJ, Lee HJ, et al. Collateral and permeability imaging derived from dynamic contrast material-enhanced MR angiography in prediction of PH 2 hemorrhagic transformation after acute ischemic stroke: a pilot study. Neuroradiology. 2021; 63:1471–1479.
Article
40. Lee HJ, Roh HG, Lee SB, Jeon YS, Park JJ, Lee TJ, et al. Collateral estimation by susceptibility-weighted imaging and prediction of functional outcomes after acute anterior circulation ischemic stroke. Sci Rep. 2021; 11:21370.
Article
41. Lu X, Meng L, Zhou Y, Wang S, Fawaz M, Wang M, et al. Quantitative susceptibility-weighted imaging may be an accurate method for determining stroke hypoperfusion and hypoxia of penumbra. Eur Radiol. 2021; 31:6323–6333.
Article
42. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981; 54:773–782.
Article
43. Marcoux FW, Morawetz RB, Crowell RM, DeGirolami U, Halsey JH Jr. Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 1982; 13:339–346.
Article
44. Hoving JW, Marquering HA, Majoie CBLM, Yassi N, Sharma G, Liebeskind DS, et al. Volumetric and spatial accuracy of computed tomography perfusion estimated ischemic core volume in patients with acute ischemic stroke. Stroke. 2018; 49:2368–2375.
Article
45. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. The performance of MRI-based cerebral blood flow measurements in acute and subacute stroke compared with 15O-water positron emission tomography: identification of penumbral flow. Stroke. 2009; 40:2413–2421.
Article
46. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke. 2012; 43:2986–2991.
47. Boers AMM, Jansen IGH, Beenen LFM, Devlin TG, San Roman L, Heo JH, et al. Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trials. J Neurointerv Surg. 2018; 10:1137–1142.
Article
48. Albers GW. Late window paradox. Stroke. 2018; 49:768–771.
Article
49. Boisseau W, Fahed R, Lapergue B, Desilles JP, Zuber K, Khoury N, ETIS Investigators, et al. Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study. Stroke. 2019; 50:2364–2370.
Article
50. Mokli Y, Pfaff J, Dos Santos DP, Herweh C, Nagel S. Computer-aided imaging analysis in acute ischemic stroke - background and clinical applications. Neurol Res Pract. 2019; 1:23.
Article
Full Text Links
  • NI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr